Jacob Elguicze Biography and Net Worth

SVP, Chief Financial Officer of Embecta

Jake Elguicze serves as as embecta’s Chief Financial Officer. Previously Jake was with Teleflex, a $2.5 billion global provider of medical technologies, where he served as the company's Treasurer and Head of Investor Relations. Jake is a CPA and began his career in public accounting with PricewaterhouseCoopers before spending 8 years at Motorola in operating finance roles.

Jake joined Teleflex in 2006 to build out the financial planning and analysis function. He assumed responsibility for investor relations in 2009 and added the Treasurer role in 2011, where he transformed the capital structure to support the company’s new M&A strategy.

Jake earned a Bachelor of Science in Accounting from the University of Scranton in Scranton, PA, and a Master of Business Administration in Finance from St. Joseph’s University in Philadelphia, PA.

What is Jacob Elguicze's net worth?: The estimated net worth of Jacob Elguicze is at least $1.59 million as of August 12th, 2026. Mr. Elguicze owns 309,139 shares of Embecta stock worth more than $1,587,429 as of August 13th. This net worth estimate does not reflect any other assets that Mr. Elguicze may own. Learn More about Jacob Elguicze's net worth.
How do I contact Jacob Elguicze?: The corporate mailing address for Mr. Elguicze and other Embecta executives is , , . Embecta can also be reached via phone at 201-847-6880 and via email at [email protected]. Learn More on Jacob Elguicze's contact information.
Has Jacob Elguicze been buying or selling shares of Embecta?: Over the course of the past ninety days, Jacob Elguicze has bought $93,400.00 in shares of Embecta stock. Most recently, on Wednesday, August 12th, Jacob Elguicze bought 20,000 shares of Embecta stock. The stock was acquired at an average cost of $4.67 per share, with a total value of $93,400.00. Following the completion of the transaction, the chief financial officer now directly owns 309,139 shares of the company's stock, valued at $1,443,679.13. Learn More on Jacob Elguicze's trading history.
Who are Embecta's active insiders?: Embecta's insider roster includes Jacob Elguicze (SVP, Chief Financial Officer), Devdatt Kurdikar (CEO), Jeffrey Mann (General Counsel and Head of Business Development), and David Melcher (Director). Learn More on Embecta's active insiders.
Are insiders buying or selling shares of Embecta?: During the last year, Embecta insiders bought shares 3 times. They purchased a total of 70,000 shares worth more than $334,200.00. The most recent insider tranaction occured on August, 12th when CEO Devdatt Kurdikar bought 30,000 shares worth more than $141,000.00. Insiders at Embecta own 1.3% of the company. Learn More about insider trades at Embecta.
Information on this page was last updated on 8/12/2026.

Jacob Elguicze Insider Trading History at Embecta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/12/2026	Buy	20,000	$4.67	$93,400.00	309,139
8/10/2023	Buy	4,625	$21.66	$100,177.50	66,027

Jacob Elguicze Buying and Selling Activity at Embecta

Embecta Company Overview

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $5.11

$4.72

$5.22

50 Day Range

MA: $3.43

$3.03

$4.99

2 Week Range

Now: $5.11

$2.77

$15.55

Volume

2,618,144 shs

Average Volume

1,602,541 shs

Market Capitalization

$289.53 million

P/E Ratio

3.45

Dividend Yield

0.80%

Beta

0.81